142 related articles for article (PubMed ID: 17387660)
1. Imaging of selective nuclear receptor modulator-induced conformational changes in the nuclear receptor to allow interaction with coactivator and corepressor proteins in living cells.
Awais M; Sato M; Umezawa Y
Chembiochem; 2007 May; 8(7):737-43. PubMed ID: 17387660
[TBL] [Abstract][Full Text] [Related]
2. Optical probes to identify the glucocorticoid receptor ligands in living cells.
Awais M; Sato M; Umezawa Y
Steroids; 2007 Dec; 72(14):949-54. PubMed ID: 17897691
[TBL] [Abstract][Full Text] [Related]
3. A fluorescent indicator to visualize ligand-induced receptor/coactivator interactions for screening of peroxisome proliferator-activated receptor gamma ligands in living cells.
Awais M; Sato M; Umezawa Y
Biosens Bioelectron; 2007 May; 22(11):2564-9. PubMed ID: 17095203
[TBL] [Abstract][Full Text] [Related]
4. Corepressor recruitment by agonist-bound nuclear receptors.
White JH; Fernandes I; Mader S; Yang XJ
Vitam Horm; 2004; 68():123-43. PubMed ID: 15193453
[TBL] [Abstract][Full Text] [Related]
5. A genetically encoded fluorescent indicator capable of discriminating estrogen agonists from antagonists in living cells.
Awais M; Sato M; Sasaki K; Umezawa Y
Anal Chem; 2004 Apr; 76(8):2181-6. PubMed ID: 15080726
[TBL] [Abstract][Full Text] [Related]
6. The coactivator LXXLL nuclear receptor recognition motif.
Savkur RS; Burris TP
J Pept Res; 2004 Mar; 63(3):207-12. PubMed ID: 15049832
[TBL] [Abstract][Full Text] [Related]
7. Conformational adaptation of nuclear receptor ligand binding domains to agonists: potential for novel approaches to ligand design.
Togashi M; Borngraeber S; Sandler B; Fletterick RJ; Webb P; Baxter JD
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):127-37. PubMed ID: 15860255
[TBL] [Abstract][Full Text] [Related]
8. Activity of androgen receptor antagonist bicalutamide in prostate cancer cells is independent of NCoR and SMRT corepressors.
Hodgson MC; Astapova I; Hollenberg AN; Balk SP
Cancer Res; 2007 Sep; 67(17):8388-95. PubMed ID: 17804755
[TBL] [Abstract][Full Text] [Related]
9. Direct association between the CREB-binding protein (CBP) and nuclear receptor corepressor (N-CoR).
Cowger JJ; Torchia J
Biochemistry; 2006 Nov; 45(44):13150-62. PubMed ID: 17073437
[TBL] [Abstract][Full Text] [Related]
10. Ligand-selective transactivation and transrepression via the glucocorticoid receptor: role of cofactor interaction.
Ronacher K; Hadley K; Avenant C; Stubsrud E; Simons SS; Louw A; Hapgood JP
Mol Cell Endocrinol; 2009 Feb; 299(2):219-31. PubMed ID: 19007848
[TBL] [Abstract][Full Text] [Related]
11. Molecular dynamics simulations for human CAR inverse agonists.
Jyrkkärinne J; Küblbeck J; Pulkkinen J; Honkakoski P; Laatikainen R; Poso A; Laitinen T
J Chem Inf Model; 2012 Feb; 52(2):457-64. PubMed ID: 22233089
[TBL] [Abstract][Full Text] [Related]
12. Agonist versus antagonist induce distinct thermodynamic modes of co-factor binding to the glucocorticoid receptor.
Kroe RR; Baker MA; Brown MP; Farrow NA; Gautschi E; Hopkins JL; LaFrance RR; Kronkaitis A; Freeman D; Thomson D; Nabozny G; Grygon CA; Labadia ME
Biophys Chem; 2007 Jul; 128(2-3):156-64. PubMed ID: 17466438
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of MAPK-signaling pathway promotes the interaction of the corepressor SMRT with the human androgen receptor and mediates repression of prostate cancer cell growth in the presence of antiandrogens.
Eisold M; Asim M; Eskelinen H; Linke T; Baniahmad A
J Mol Endocrinol; 2009 May; 42(5):429-35. PubMed ID: 19223455
[TBL] [Abstract][Full Text] [Related]
14. Fluorescence resonance energy transfer analysis of alpha 2a-adrenergic receptor activation reveals distinct agonist-specific conformational changes.
Zürn A; Zabel U; Vilardaga JP; Schindelin H; Lohse MJ; Hoffmann C
Mol Pharmacol; 2009 Mar; 75(3):534-41. PubMed ID: 19106230
[TBL] [Abstract][Full Text] [Related]
15. Implications of the binding of tamoxifen to the coactivator recognition site of the estrogen receptor.
Kojetin DJ; Burris TP; Jensen EV; Khan SA
Endocr Relat Cancer; 2008 Dec; 15(4):851-70. PubMed ID: 18755852
[TBL] [Abstract][Full Text] [Related]
16. Analysis of ligand-dependent recruitment of coactivator peptides to RXRbeta in a time-resolved fluorescence resonance energy transfer assay.
Stafslien DK; Vedvik KL; De Rosier T; Ozers MS
Mol Cell Endocrinol; 2007 Jan; 264(1-2):82-9. PubMed ID: 17184907
[TBL] [Abstract][Full Text] [Related]
17. Genetically encoded optical probes for imaging cellular signaling pathways.
Umezawa Y
Biosens Bioelectron; 2005 Jun; 20(12):2504-11. PubMed ID: 15854822
[TBL] [Abstract][Full Text] [Related]
18. Use of homogeneous time-resolved fluorescence energy transfer in the measurement of nuclear receptor activation.
Zhou G; Cummings R; Hermes J; Moller DE
Methods; 2001 Sep; 25(1):54-61. PubMed ID: 11558997
[TBL] [Abstract][Full Text] [Related]
19. Dynamics of coregulator-induced conformational perturbations in androgen receptor ligand binding domain.
Zakharov MN; Pillai BK; Bhasin S; Ulloor J; Istomin AY; Guo C; Godzik A; Kumar R; Jasuja R
Mol Cell Endocrinol; 2011 Jul; 341(1-2):1-8. PubMed ID: 21605623
[TBL] [Abstract][Full Text] [Related]
20. Panning for SNuRMs: using cofactor profiling for the rational discovery of selective nuclear receptor modulators.
Kremoser C; Albers M; Burris TP; Deuschle U; Koegl M
Drug Discov Today; 2007 Oct; 12(19-20):860-9. PubMed ID: 17933688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
